Back to Search Start Over

Synthesis of 8-Substituted Analogues of Cyclic ADP-4-Thioribose and Their Unexpected Identification as Ca 2+ -Mobilizing Full Agonists.

Authors :
Takano S
Tsuzuki T
Murayama T
Kameda T
Kumaki Y
Sakurai T
Fukuda H
Watanabe M
Arisawa M
Shuto S
Source :
Journal of medicinal chemistry [J Med Chem] 2017 Jul 13; Vol. 60 (13), pp. 5868-5875. Date of Electronic Publication: 2017 Jul 03.
Publication Year :
2017

Abstract

A series of 8-substituted analogues of cyclic ADP-4-thioribose (cADPtR, 3), which is a stable equivalent of Ca <superscript>2+</superscript> -mobilizing second messenger cyclic ADP-ribose (cADPR, 1), were designed as potential pharmacological tools for studies on cADPR-modulated Ca <superscript>2+</superscript> signaling pathways. These 8-amino analogue (8-NH <subscript>2</subscript> -cADPtR, 4), 8-azido analogue (8-N <subscript>3</subscript> -cADPtR, 5), and 8-chloro analogue (8-Cl-cADPtR, 6) were efficiently synthesized, where the stereoselective N1-β-thioribosyladenine ring closure reaction via an α/β-equilibrium of the 1-aminothioribose derivative and construction of the characteristic 18-membered pyrophosphate ring by Ag <superscript>+</superscript> -promoted activation of a phenyl phosphorothioate type substrate were the two key steps. Although 8-NH <subscript>2</subscript> -cADPR (2) is a well-known potent antagonist against cADPR-inducing Ca <superscript>2+</superscript> -release, the 4-thioribose congener 8-NH <subscript>2</subscript> -cADPtR turned out unexpectedly to be a full agonist in sea urchin egg homogenate evaluation system. This important finding suggested that the ring-oxygen in the N1-ribose of cADPR analogues is essential for the antagonistic activity in the Ca <superscript>2+</superscript> -signaling pathway, which can contribute to clarify the structure-agonist/antagonist activity relationship.

Details

Language :
English
ISSN :
1520-4804
Volume :
60
Issue :
13
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
28636353
Full Text :
https://doi.org/10.1021/acs.jmedchem.7b00540